|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/17 | |
| A61K 35/15 | |||
| A61P 35/00 |
| (11) | Number of the document | 3294304 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16724230.4 |
| Date of filing the European patent application | 2016-05-11 | |
| (97) | Date of publication of the European application | 2018-03-21 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/031784 |
| Date | 2016-05-11 |
| (87) | Number | WO 2016/183153 |
| Date | 2016-11-17 |
| (30) | Number | Date | Country code |
| 201562160549 P | 2015-05-12 | US |
| (72) |
O`REILLY, Richard, John, US
PROCKOP, Susan Elizabeth, US
HASAN, Aisha Nasreen, US
DOUBROVINA, Ekaterina, US
|
| (73) |
Memorial Sloan Kettering Cancer Center,
1275 York Avenue, New York, NY 10065,
US
|
| (54) | METHODS OF TREATING EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS BY T CELL THERAPY |
| METHODS OF TREATING EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS BY T CELL THERAPY |